| Literature DB >> 36237532 |
Alessio Daniele1, Samuel J E Lucas1,2, Catarina Rendeiro1,2.
Abstract
The growing prevalence of physical inactivity in the population highlights the urgent need for a more comprehensive understanding of how sedentary behaviour affects health, the mechanisms involved and what strategies are effective in counteracting its negative effects. Physical inactivity is an independent risk factor for different pathologies including atherosclerosis, hypertension and cardiovascular disease. It is known to progressively lead to reduced life expectancy and quality of life, and it is the fourth leading risk factor for mortality worldwide. Recent evidence indicates that uninterrupted prolonged sitting and short-term inactivity periods impair endothelial function (measured by flow-mediated dilation) and induce arterial structural alterations, predominantly in the lower body vasculature. Similar effects may occur in the cerebral vasculature, with recent evidence showing impairments in cerebral blood flow following prolonged sitting. The precise molecular and physiological mechanisms underlying inactivity-induced vascular dysfunction in humans are yet to be fully established, although evidence to date indicates that it may involve modulation of shear stress, inflammatory and vascular biomarkers. Despite the steady increase in sedentarism in our societies, only a few intervention strategies have been investigated for their efficacy in counteracting the associated vascular impairments. The current review provides a comprehensive overview of the evidence linking acute and short-term physical inactivity to detrimental effects on peripheral, central and cerebral vascular health in humans. We further examine the underlying molecular and physiological mechanisms and attempt to link these to long-term consequences for cardiovascular health. Finally, we summarize and discuss the efficacy of lifestyle interventions in offsetting the negative consequences of physical inactivity.Entities:
Keywords: cerebrovascular; endothelial; inactivity; sedentary; sitting; vascular
Year: 2022 PMID: 36237532 PMCID: PMC9553009 DOI: 10.3389/fphys.2022.998380
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
The acute effects of prolonged sitting on vascular health biomarkers.
| Outcome measures | ||||||
|---|---|---|---|---|---|---|
| References | Population (N) | Artery | Sitting time (h) | %FMD | Shear rate/stress | Other |
|
| Early middle-aged at risk (25) | >7 | SBP: ↑; DBP: ↑; MAP: ↑; PWV: ↑ | |||
|
| Young healthy (11) | SFA | 3 | ↓ | ↓ | ET-1: ↔ |
|
| Young healthy (26) | SFA | 2 | ↔ | ↓ | ET-1: ↔; PWV: ↔ |
|
| Young healthy (10) | BA | ∼1.5 | ↔ | ↔ | |
|
| Young healthy (15) | SFA | 4 | ↔ | ↔ | |
|
| Young healthy (12) | PA - BA | 4 | BA: ↓ | PA: ↔ | |
|
| Late middle-aged at risk (19) | SFA - BA | 5 | SFA: ↓; BA: ↔ | SFA: ↔; BA: ↔ | ET-1: ↔ |
|
| Young (overweight/obese) (20) | PTA | 3 | ↔ | ↓ | Diameter: ↓; L-FMC: ↔; PWV: ↑ |
|
| Young healthy (26) | CFA | 1.5 | PLM-induced hyperaemia [LBFΔpeak (men: ↓; women: ↓)] | ||
|
| Young healthy (20) | 3 | PWV: ↑; TSI: ↓ | |||
|
| Young healthy (20) | CFA | 3 | Active: ↔; non-active: ↔ | PLM-induced hyperaemia [∆LBF (Active: ↓; non-active: ↓); LBF AUC (Active: ↓; non-active: ↓)] | |
|
| Young healthy (10) | CFA | 3 | PLM-induced hyperaemia (∆LBF: ↓; LBF AUC: ↓) | ||
|
| Elderly at risk (24) | SFA | 3 | ↔ | ||
|
| Young healthy (12) | PA - BA | 2.5 | PA: ↓; BA: ↓ | PWV: ↔; AIx: ↓; TSI: ↓ | |
|
| Late middle-aged at risk (14) | 4 | PWV: ↔ | |||
|
| Early middle-aged (overweight/obese) (13) | PA | 4 | ↓ | ↓ | |
|
| Young healthy (21) | PA | 3 | ↓ | ↓ | Blood flow: ↓ |
|
| Young healthy girls (9) | SFA | 3 | ↓ | ↔ | |
|
| Young healthy (11) | PA | 3 | ↓ | ↓ | |
|
| Young healthy (15) | PA | 3 | ↓ | ↓ | |
|
| Young healthy (19) | PA | 3 | ↓ | ↓ | |
|
| Young healthy (19) | PA | 3 | Active: ↔; non-active: ↓ | Active: ↓; non-active: ↓ | |
|
| Young healthy (20) | PA | 3 | Men: ↓; women: ↓ | Men: ↓; women: ↓ | L-FMC (men: ↓; women: ↓) |
|
| Young healthy (18) | PA | 3 | ↓ | ↓ | |
|
| Young healthy (11) | PA | 3 | ↔ | ↓ | |
|
| Young healthy (18) | PA | 6 | ↔ | ↓ | Blood flow: ↓ |
|
| Middle-aged healthy (15) | 0.5 | PWV: ↔ | |||
|
| Young healthy (11) | PA - BA | 6 | PA: ↓; BA: ↔ | PA: ↓; BA: ↓ | |
|
| Young healthy (10) | PA | 3 | ↓ | ↓ | |
|
| Young at risk (13) | SFA | 3.5 | ↔ | ↔ | |
|
| Middle-aged/elderly at risk (24) | SFA | 7 | ↔ | ↔ | ET-1: ↓ |
|
| Young healthy (12) | SFA - BA | 3 | SFA: ↓; BA: ↔ | SFA: ↓; BA: ↔ | |
|
| Young healthy (12) | SFA | 3 | ↓ | ↓ | |
|
| Young healthy (11) | SFA | 3 | ↓ | ↓ | |
|
| Young Healthy (11) | SFA | 0.5 | ↔ | ↓ | PWV: ↔ |
|
| Young healthy (20) | PA | 3 | Men: ↓; women ↔ | Men: ↓; women ↓ | |
|
| Young healthy (14) | PA | 0.17 | ↔ | ↓ | |
AIx, augmentation index; AUC, area under the curve; BA, brachial artery; CFA, common femoral artery; DBP, diastolic blood pressure; ET-1, endothelin-1; LBF, leg blood flow; L-FMC, low-flow mediated constriction; MAP, mean arterial pressure; PA, popliteal artery; PLM, passive leg movement; PTA, posterior tibial artery; PWV, pulse wave velocity; SBP, systolic blood pressure; SFA, superficial femoral artery; TSI, tissue saturation index.
FIGURE 1Summary of the negative effects of both acute (sitting) and short-term (e.g., step-reduction, limb immobilization, bed rest) inactivity protocols on peripheral vascular health in humans: sitting for up to 6 h results in a reduction in FMD, shear stress/rate, and cerebrovascular function; short-term reductions in physical activity of up to 15 days (or more) result in declines in arterial diameter. All inactivity protocols (acute and short-term) have been reported to increase blood pressure and arterial stiffness. FMD: Flow-mediated dilation.
The effects of short-term inactivity on vascular health biomarkers.
| Outcome measures | |||||||
|---|---|---|---|---|---|---|---|
| References | Population (N) | Artery | Inactivity model (days) | %FMD | Shear rate/stress | Diameter | Other |
|
| Young healthy (13) | BA | Forearm immobilization (8) | ↔ | ↔ | ||
|
| Young healthy (16) | SFA - CFA - BA- CCA | Bed rest (52) | SFA: ↑ | SFA: ↓; CFA: ↓; BA: ↓; CCA: ↔ | ||
|
| Young healthy (28) | BA | Step reduction (14) | ↓ | ↔ | ||
|
| Young healthy (11) | PA - BA | Step reduction (5) | PA: ↓; BA: ↔ | PA: ↔; BA: ↓ | EMPs: ↑ | |
|
| Young healthy (31) | SFA | Leg immobilization (14) | ↔ | ↔ | ↓ | PWV: ↔ |
|
| Young healthy (22) | BA | Bed rest (5) | ↔ | ↓ | ||
|
| Young healthy (21) | CFA | Leg immobilization (10) | ↓ | PLM-induced hyperaemia: ↓; VEGF: ↓; ET-1: ↔ | ||
|
| Young healthy (5) | SFA - BA | Bed rest (5) | SFA: ↓; BA: ↓ | SFA: ↔; BA: ↔ | SFA: ↔; BA: ↔ | PWV: ↔; AIx: ↑ |
|
| Young healthy (15) | PA - CFA - CCA | Leg immobilization (12) | PA: ↑ | PA: ↑; CFA: ↑ | PA: ↓; CFA: ↓; CCA: ↔ | |
|
| Young healthy (8) | CFA | Leg immobilization (7) | ↔ | ↓ | IMT: ↔; Vascular conductance: ↓ | |
|
| Young healthy (13) | PA | Step reduction (5) | ↓ | ↔ | ||
AIx, augmentation index; BA, brachial artery; CCA, common carotid artery; CFA, common femoral artery; EMPs, endothelial microparticles; ET-1, endothelin-1; IMT, intima-media thickness; PA, popliteal artery; PLM, passive leg movement; PWV, pulse wave velocity; SFA, superficial femoral artery; VEGF, vascular endothelial growth factor.
FIGURE 2Proposed underpinning mechanisms by which physical inactivity induces endothelial dysfunction in humans include modulation of i) molecular components associated with vasodilation/vasoconstriction, vascular adhesion, inflammation, oxidative stress and insulin resistance, as well as ii) physiological components, mainly in the lower limbs, such as declines in blood flow and shear stress/rate and increases in hydrostatic pressure, blood pooling and viscosity. CRP: C-reactive protein; ET-1: Endothelin-1; ICAM-1: Intercellular adhesion molecule-1; IL-6: Interleukin-6; IL-8: Interleukin-8; NO: Nitric oxide; ROS: Reactive oxygen species; TNF-α: Tumor necrosis factor alpha; VCAM-1: Vascular cell adhesion molecule-1.
FIGURE 3Summary of intervention strategies that have been shown to be effective at preventing detrimental effects on vascular health during periods of physical inactivity. Standing, intermittent leg fidgeting, walking, running, cycling, resistance exercises, limb heating and vitamin C supplementation were shown to be effective at improving FMD and/or shear stress/rate in the context of prolonged sitting. Resistive vibration exercises, limb heating and general physical activity were shown to be effective at preventing declines in FMD and/or arterial diameter during inactivity protocols such as bed rest, step-reduction, and leg immobilization. FMD: Flow-mediated dilation.
The effects of counteracting interventions on inactivity-induced vascular dysfunction.
| Outcome measures | |||||||
|---|---|---|---|---|---|---|---|
| References | Population (N) | Artery | Inactivity model | Intervention | %FMD | Shear rate/stress | Other |
|
| Young healthy (11) | SFA | SIT (3 h) | Running (45 min, prior sitting) | ↑ | ↑ | ET-1: ↔ |
|
| Young healthy (16) | SFA - CFA - BA- CCA | Bed rest (52 days) | Resistive vibration exercise (twice daily for 30 min) | SFA: ↔ | Diameter (SFA: ↑; CFA: ↑; BA: ↔; CCA: ↔) | |
|
| Young healthy (26) | SFA | SIT (2 h) | Standing (replacing sitting with standing); Foot heating (during sitting at 49°C) | Standing: ↑; Foot heating: ↑ | Standing: ↑; Foot heating: ↑ | ET-1 (Standing: ↔; Foot heating: ↔); PWV (Standing: ↑; Foot heating: ↔) |
|
| Young healthy (10) | BA | SIT (∼1.5 h) | Callisthenics exercises (2 min every 20 min) | ↔ | ↑ | |
|
| Young healthy (15) | SFA | SIT (4 h) | 2WALK (2-min walking break every 30 min); 8WALK (8-min walking break every 2 h) | 2WALK: ↔; 8WALK: ↔ | 2WALK: ↔; 8WALK: ↔ | |
|
| Young healthy (12) | PA - BA | SIT (4 h) | Stair climbing (5 min every h) | BA: ↑ | PA: ↑ | |
|
| Late middle-aged at risk (19) | SFA - BA | SIT (5 h) | SRA (3 min every 30 min) | SFA: ↑; BA: ↔ | SFA: ↔; BA: ↔ | ET-1: ↓ |
|
| Young healthy (31) | SFA | Leg immobilization (14 days) | BFR (twice daily for 30 min); BFR + EMS (twice daily for 30 min) | ↔ | ↔ | Diameter: ↔ |
|
| Young healthy (26) | CFA | SIT (1.5 h) | Vitamin C supplementation (1 g, 90 min prior to the testing session) | PLM-induced hyperaemia [LBFΔpeak (men: ↑; women: ↔)] | ||
|
| Young healthy (20) | SIT (3 h) | Calf exercise (10 calf raises every 10 min) | PWV: ↔; TSI: ↑ | |||
|
| Young healthy (10) | CFA | SIT (3 h) | Cycling (∼45 min, prior sitting) | PLM-induced hyperaemia (∆LBF: ↑; LBF AUC: ↑) | ||
|
| Elderly at risk (24) | SFA | 16-week intervention (reduced sitting + physical activity) | ↑ | Diameter: ↑ | ||
|
| Elderly at risk (24) | SFA | SIT (3 h) | Walking (2 min every 30 min) | ↑ | ||
|
| Young healthy (21) | CFA | Leg immobilization (10 days) | Thigh heating (2 h, daily) | Diameter: ↑; PLM hyperaemia: ↑; VEGF: ↑; ET-1: ↔ | ||
|
| Late middle-aged at risk (14) | SIT (4 h) | SRA (every h) | PWV: ↔ | |||
|
| Early middle-aged (overweight/obese) (13) | PA | SIT (4 h) | Standing (10 min every h); desk pedalling (10 min every h) | Standing: ↔; desk pedalling: ↔ | Standing: ↔; desk pedalling: ↔ | |
|
| Young healthy girls (9) | SFA | SIT (3 h) | Cycling (10 min every h) | ↑ | ↔ | |
|
| Young healthy (15) | PA | SIT (3 h) | Cycling (45 min, prior sitting); standing (replacing sitting with standing) | Cycling: ↑; standing: ↑ | Cycling: ↑; standing: ↑ | |
|
| Young healthy (11) | PA | SIT (3 h) | Intermittent leg fidgeting (cycle: 1 min on, 4 min off) | ↑ | ↑ | |
|
| Young healthy (19) | PA | SIT (3 h) | Fish oil supplementation (8 capsules per day, for 8 weeks) | ↔ | ↔ | |
|
| Young healthy (18) | PA | SIT (6 h) | Standing (replacing sitting with standing); activity breaks (2 min of walking every 30 min) | Standing: ↔; activity breaks: ↔ | Standing: ↑; activity breaks: ↑ | Blood flow: (Standing: ↑; activity breaks: ↑) |
|
| Young healthy (11) | PA - BA | SIT (6 h) | Walking (10 min, after sitting) | PA: ↑; BA: ↔ | PA: ↑; BA: ↔ | |
|
| Young healthy (10) | PA | SIT (3 h) | Foot heating (during sitting at 42°C) | ↑ | ↑ | |
|
| Young at risk (13) | SFA | SIT (3.5 h) | SRA (3 min every 30 min) | ↔ | ↑ | |
|
| Middle-aged/elderly at risk (24) | SFA | SIT (7 h) | SRA3 (3 min of SRA every 30 min); SRA6 (6 min of SRA every 60 min) | SRA3: ↑; SRA6: ↔ | SRA3: ↑; SRA6: ↑ | ET-1 (SRA3: ↔; SRA6: ↔) |
|
| Young healthy (13) | PA | Step reduction (5 days) | Intermittent foot heating (3 times [30 min each] per day at 42°C) | ↑ | Diameter: ↔ | |
|
| Young healthy (12) | SFA | SIT (3 h) | Walking (5 min every h) | ↑ | ↔ | |
|
| Young healthy (11) | SFA | SIT (3 h) | Vitamin C supplementation (1 tablet of 1 g after 30 min; 1 tablet of 500 mg after 90 min) | ↑ | ↔ | |
|
| Young Healthy (11) | SFA | SIT (0.5 h) | Replacing normal sitting with sitting cross-legged | ↔ | ↑ | PWV: ↔ |
BA, brachial artery; BFR, blood flow restriction; CCA, common carotid artery; CFA, common femoral artery; EMS, electrical muscle stimulation; ET-1, endothelin-1; LBF, leg blood flow; PA, popliteal artery; PLM, passive leg movement; PWV, pulse wave velocity; SFA, superficial femoral artery; SIT, sitting; SRA, simple resistance activities; TSI, tissue saturation index; VEGF, vascular endothelial growth factor.